Epitope mapping is a crucial process in understanding how IgE antibodies recognize specific regions of cashew allergenic proteins. This helps in identifying cross-reactivity with other nuts and potential targets for hypoallergenic food processing and immunotherapy.
Overview of Cashew Allergenic Proteins and Their Epitopes
Cashew nuts contain multiple IgE-binding proteins, mainly Ana o 1, Ana o 2, Ana o 3, which contain linear (continuous) and conformational (discontinuous) epitopes.
| Allergen | Protein family | Molecular weight | Epitope studies | Clinically important cross-reactivity |
|---|---|---|---|---|
| Ana o 1 | Vicilin-like (7S globulin) | 50 kDa | Linear IgE epitopes mapped in published peptide studies | Pistachio (Pis v 3) |
| Ana o 2 | Legumin-like (11S globulin) | 55 kDa | Linear and conformational epitopes studied | Pistachio (Pis v 2, Pis v 5) |
| Ana o 3 | 2S albumin | 14 kDa | Linear and conformational epitopes studied; key marker of severe allergy | Pistachio (Pis v 1) |
| Ana o 4 | PR-10 (Bet v 1-related) | 17 kDa | — | Birch pollen (Bet v 1) |
| Ana o 5 | nsLTP1 | 9 kDa | — | LTP foods (e.g. peach) |
Epitope Mapping of Major Cashew Allergens
Published studies using overlapping peptides have mapped linear IgE-binding epitopes on Ana o 1, Ana o 2 and Ana o 3, and later work has examined conformational (shape-dependent) epitopes on Ana o 2 and Ana o 3. The exact positions differ between studies and between patients, so specific amino-acid ranges are not reproduced here.
Detailed epitope (amino-acid) maps previously shown here have been removed because they could not be matched to published studies. Exact epitope positions vary between studies and between patients.
Heat and Enzymatic Stability of Cashew Epitopes
| Allergen | Heat stability | Digestive stability | Effect of processing |
|---|---|---|---|
| Ana o 1 | Moderate to high | Moderate | Largely survives roasting |
| Ana o 2 | Moderate to high | Moderate | Largely survives roasting |
| Ana o 3 | High | High | Survives roasting and digestion |
| Ana o 4 | Low | Low | Usually destroyed by roasting or cooking |
| Ana o 5 | High | High | Survives cooking and digestion |
Key Observations
- Ana o 3 (2S Albumin) is the most stable allergen, surviving heat and stomach digestion.
- Processing (roasting, grinding) can increase allergenicity by exposing more IgE-binding sites.
Structural Analysis of IgE-Binding Sites
Structural studies of Ana o 2 and Ana o 3 help explain why these proteins survive heat and digestion. In routine care, allergists measure IgE to whole cashew extract or to whole components such as Ana o 3. Standard tests (for example ImmunoCAP) do not identify individual epitopes; peptide-level testing remains a research tool, and peptide-based treatments are still pre-clinical.
Cross-Reactivity with Other Allergens
Cashew allergens share close sequence homology with pistachio allergens, which explains the very high clinical cross-reactivity between the two nuts. Similarities with peanut and other tree-nut allergens are weaker; co-allergy with them is common but usually reflects separate sensitization. Ana o 4 relates to the birch-pollen allergen Bet v 1.
| Food | What is known |
|---|---|
| Pistachio | Very high cross-reactivity through all three storage proteins (Ana o 1–3 with Pis v 1–3 and Pis v 5); most cashew-allergic people react to pistachio |
| Peanut, walnut, Brazil nut | Co-allergy is common, but shared epitopes have not been shown to explain it; usually separate sensitization |
| Birch pollen | Ana o 4 (PR-10) relates to Bet v 1; usually mild oral symptoms |
| Peach, apple, cherry (LTP foods) | Ana o 5 (LTP); possible in LTP-sensitized people |
Implications for Allergen Detection and Immunotherapy
Diagnostic Testing
- Epitope-based IgE assays:
- Component-resolved diagnostics (CRD) measure IgE to whole cashew components such as Ana o 3; testing at the level of individual epitopes is still a research tool.
- Skin Prick Test (SPT) vs. Serum IgE Testing:
- SPT: Tests whole cashew extract, less specific.
- Serum IgE (ImmunoCAP, ELISA): Measures IgE to whole cashew extract or to individual components (for example Ana o 3); it does not identify peptide sequences.
Immunotherapy (Desensitization)
- Targeting Linear Epitopes:
- Potential hypoallergenic variants could be engineered by modifying epitope sequences.
- Peptide-Based Vaccines:
- Small, non-IgE-binding peptide fragments may one day be used in oral or sublingual immunotherapy (OIT/SLIT); this is still pre-clinical research.
- Epitope Masking via Enzymatic Processing:
- Certain food processing methods (fermentation, enzymatic hydrolysis) may reduce allergenicity by disrupting IgE-binding regions.
Conclusion
- Cashew allergenic proteins (Ana o 1, Ana o 2, Ana o 3) contain both linear and conformational IgE-binding epitopes.
- Ana o 3 is the most stable allergen, resistant to heat and digestion, making it a major cause of severe reactions.
- Cross-reactivity is strongest with pistachio, whose allergens closely resemble those of cashew; co-allergy with peanut and walnut is common but usually reflects separate sensitization.
- Epitope mapping may in future improve diagnostics and therapies through hypoallergenic protein modifications and immunotherapy.